Risedronate for the Treatment of Osteoporosis for People With Spinal Cord Injury

• Status: Completed
• Trial end date: 2009-03-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to find out if risedronate works for the treatment of osteoporosis for people with spinal cord injury.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Toronto Rehabilitation Institute
• Collaborators: St. Joseph's Health Care London; The Physicians' Services Incorporated Foundation
• Treatments: Etidronic Acid; Risedronate Sodium; Risedronic Acid

Criteria

Inclusion Criteria:

• Traumatic spinal cord injury of greater than 18 months

• Osteopenia or osteoporosis of the hip

• Must be able to swallow tablets and sit upright

Exclusion Criteria:

• Bilateral heterotopic ossification

• Bilateral lower extremity metal implants

• Pregnant or lactating females

• Paget's disease

• Osteomalacia

• Steroid induced bone loss

• Untreated parathyroid or thyroid disease

• Symptomatic hypocalcemia or hypophosphatemia

• Treatment in the last year with calcitonin, fluoride or anabolic steroids

• Current treatment with prednisone